TOF Versus SOX in Metastatic Gastric Cancer

• Status: Completed
• Trial end date: 2014-06-01

Summary

This study was designed to compare the efficacy and safety of aclitaxel/oxaliplatin/fluorouracil (TOF) regimen and S-1/oxaliplatin (SOX) regimen for metastatic gastric cancer (GC) patients.

• Phase: Phase 2/Phase 3

Details

• Lead Sponsor: The First People's Hospital of Changzhou
• Treatments: Albumin-Bound Paclitaxel; Fluorouracil; Oxaliplatin; Paclitaxel